Summary of Significant Accounting Policies (Tables)
|
9 Months Ended |
Mar. 31, 2025 |
|---|
| Summary of Significant Accounting Policies |
|
| Schedule of vendor concentration risk percentage |
| | | | | | | | | | | | | | | | Three Months Ended | | | Nine Months Ended | | | | | March 31, | | | March 31, | | | | | 2025 | | | 2024 | | | 2025 | | | 2024 | | | Vendor A | | 29 | % | | 27 | % | | 27 | % | | 26 | % | | Vendor B | | 10 | % | | 10 | % | | 10 | % | | 10 | % | |
|
| Schedule of revenue by geographical region |
| | | | | | | | | | | | | | | Three Months Ended | | | | March 31, | | | | 2025 | | | 2024 | | United States | | $ | 7,227,043 | | 57.0 | % | | $ | 7,289,260 | | 60.2 | % | Europe | | | 4,046,925 | | 32.0 | % | | | 3,767,945 | | 31.1 | % | Rest of World | | | 1,387,395 | | 11.0 | % | | | 1,058,467 | | 8.7 | % | Total | | $ | 12,661,363 | | 100 | % | | $ | 12,115,672 | | 100 | % |
| | | | | | | | | | | | | | | Nine Months Ended | | | | March 31, | | | | 2025 | | | 2024 | | United States | | $ | 21,271,525 | | 58.1 | % | | $ | 19,220,592 | | 59.1 | % | Europe | | | 11,619,759 | | 31.7 | % | | | 10,225,116 | | 31.5 | % | Rest of World | | | 3,728,780 | | 10.2 | % | | | 3,044,677 | | 9.4 | % | Total | | $ | 36,620,064 | | 100 | % | | $ | 32,490,385 | | 100 | % |
|
| Schedule of accounts receivable by geographical region |
| | | | | | | | | | | | | | | As of March 31, 2025 | | | As of June 30, 2024 | | United States | | $ | 4,292,963 | | 56.5 | % | | $ | 4,125,696 | | 60.0 | % | Europe | | | 2,605,952 | | 34.3 | % | | | 2,082,900 | | 30.2 | % | Rest of World | | | 705,143 | | 9.3 | % | | | 671,204 | | 9.8 | % | Total | | $ | 7,604,058 | | 100 | % | | $ | 6,879,800 | | 100 | % |
|
| Schedule of foreign currency exchange rate |
| | | | | | | | | | | Nine Months Ended | | Year Ended | | | March 31, | | June 30, | | | 2025 | | 2024 | | 2024 | | 2023 | Period end Euro: US Dollar exchange rate | | 1.08 | | 1.08 | | 1.07 | | 1.09 | Average period Euro: US Dollar exchange rate | | 1.07 | | 1.08 | | 1.08 | | 1.05 | | | | | | | | | | Period end GBP: US Dollar exchange rate | | 1.29 | | 1.26 | | 1.26 | | 1.27 | Average period GBP: US Dollar exchange rate | | 1.28 | | 1.26 | | 1.26 | | 1.20 | | | | | | | | | | Period end Japanese Yen: US Dollar exchange rate | | 0.007 | | 0.007 | | 0.006 | | 0.007 | Average period Japanese Yen: US Dollar exchange rate | | 0.007 | | 0.007 | | 0.007 | | 0.007 | | | | | | | | | | Period end Mexican Peso: US Dollar exchange rate | | 0.05 | | 0.06 | | 0.05 | | 0.06 | Average period Mexican Peso: US Dollar exchange rate | | 0.05 | | 0.06 | | 0.06 | | 0.05 |
|
| Schedule of earnings per share, basic and diluted |
| | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | | March 31, | | March 31, | | | 2025 | | 2024 | | 2025 | | 2024 | | | | | | | | | | | | | | Net income (loss) available to common shareholders | | $ | 216,470 | | $ | 76,301 | | $ | (1,094,760) | | $ | (965,370) | | | | | | | | | | | | | | Weighted average commons shares - basic | | | 31,033,022 | | | 30,020,652 | | | 30,597,410 | | | 28,377,199 | Dilutive effect of outstanding warrants and stock options | | | 1,080,595 | | | 938,087 | | | — | | | — | Dilutive effect of unvested restricted common stock | | | 26,318 | | | 2,552,503 | | | — | | | — | Weighted average commons shares - diluted | | | 32,139,935 | | | 33,511,242 | | | 30,597,410 | | | 28,377,199 | | | | | | | | | | | | | | Net income (loss) per common share: | | | | | | | | | | | | | Basic | | $ | 0.01 | | $ | 0.00 | | $ | (0.04) | | $ | (0.03) | Diluted | | $ | 0.01 | | $ | 0.00 | | $ | (0.04) | | $ | (0.03) |
1 Weighted average stock options excluded due to anti-dilution were 770,287 and 8,000 during the three months ended March 31, 2025 and 2024, respectively and 2,791,702 and 2,641,492 during the nine months ended March 31, 2025 and 2024, respectively. Shares of unvested restricted stock that were considered antidilutive were 2,139,100 and 2,329,900 during the three months ended March 31, 2025 and 2024, respectively and 2,221,495 and 2,715,191 during the nine months ended March 31, 2025 and 2024, respectively.
|
| Schedule of Company's assets and liabilities at fair value |
| | | | | | | | | | | | | | | | | | | | | | | | | | | As of March 31, 2025 | | As of June 30, 2024 | | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | | | | | | | | | | | | | | | | | | | | | | | | | Assets | | | | | | | | | | | | | | | | | | | | | | | | | Total assets | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | Contingent earnout liability | | $ | — | | | — | | $ | 15,110,910 | | $ | 15,110,910 | | $ | — | | | — | | $ | 12,298,114 | | $ | 12,298,114 | Total liabilities | | $ | — | | $ | — | | $ | 15,110,910 | | $ | 15,110,910 | | $ | — | | $ | — | | $ | 12,298,114 | | $ | 12,298,114 |
1 During the three and nine months ended March 31, 2025, a change in fair value of contingent liability of $405,910 and $2,812,796, respectively, were recognized as loss in the accompanying condensed consolidated statements of operations and comprehensive income (loss). During the nine months ended March 31, 2024, a change in fair value of contingent liability of $268,287, was recognized as a gain in the accompanying condensed consolidated statements of operations and comprehensive income (loss).
|